Observational multicentre prospective study to assess changes in cognitive function in patients treated with PCSK9i. Study protocol by José Seijas-Amigo, Diego Rodríguez-Penas, Ana Estany-Gestal, Pedro Suárez-Artime, María Santamaría-Cadavid, José Ramón González-Juanatey

Subjects: Get full text

Reversal of Atherosclerotic Plaque Growth and Vulnerability: Effects of Lipid-Modifying and Anti-Inflammatory Therapeutic Agents by Michail I. Papafaklis, Rafail Koros, Grigorios Tsigkas, Antonios Karanasos, Athanasios Moulias, Periklis Davlouros

Subjects: Get full text

Projected Cost Savings With Optimal Medication Adherence in Patients With Cardiovascular Disease Requiring Lipid‐Lowering Therapy: A Multinational Economic Evaluation Study by Jeong‐Yeon Cho, Fernando A. Wilson, Usa Chaikledkaew, Yingyao Chen, Arintaya Phrommintikul, Miguel Angel Diaz‐Aguilera, Zhenyue Chen, Kyoo Kim, Nathorn Chaiyakunapruk

Subjects: Get full text

Factors associated with lipid lowering therapy in the multi-ethnic study of atherosclerosis by Jing Cao, Weihua Guan, Sarah O. Nomura, Harpreet S. Bhatia, Parveen K. Garg, Michael Y. Tsai

Subjects: “…Lipid lowering therapy…”
Get full text

“Inclisiran: Early LDL-C target achievement in a real-life population” by Francesco Briani, Mauro Bagli, Gabriele Venturi, Francesco Bacchion, Antonio Mugnolo

Subjects: Get full text

Predicting plaque regression based on plaque characteristics identified by optical coherence tomography: A retrospective study by Cheng-Hui Fan, Lyu-fan Chen, Jing Cheng, Yi-Qiong Wang, Ling-Hao Xu, Ji-Ming Li

Subjects: Get full text

Achievement of guideline-based lipid goals among very-high-risk patients with atherosclerotic cardiovascular disease and type 2 diabetes: results in 213,380 individuals from the cv... by Satoshi Shoji, Nishant P. Shah, Peter Shrader, Laine E. Thomas, Jonathan D. Arnold, Nafeesa N. Dhalwani, Neena A. Thomas, Bethany Kalich, Elisa L. Priest, Mahanaz Syed, Cezary Wójcik, Eric D. Peterson, Ann Marie Navar

Subjects: Get full text